Pharmaceutical
Latest News
FDA grants Breakthrough Therapy Designation to lung cancer therapy
The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to izalontamab brengitecan (iza-bren), an investigational...
Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
Upperton Pharma Solutions has been awarded funding under the first VaxHub Sustainable Platform Funding Call to support the development of oral formula...
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
Friends of Cancer Research has announced a new collaboration with global clinical research organisation, MMS, to develop decision frameworks that will...
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
ANGLE has announced a collaboration with Myriad Genetics to assess whether circulating tumour cell (CTC) DNA harvested from blood samples using ANGLE’...
<a href="https://www.fiercepharma.com/marketing/swoop-ispot-team-tackle-tv-ad-transparency-pharma" hreflang="en">Swoop, iSpot team up to tackle TV ad transparency for pharma</a>
Swoop and iSpot have joined forces to deliver insights into cross-platform ad exposures against specific audience segments.
<a href="https://www.fiercepharma.com/manufacturing/nucleus-radiopharma-taps-former-fda-head-stephen-hahn-chief-executive" hreflang="en">Nucleus RadioPharma taps former FDA head Stephen Hahn as chief executive</a>
Nucleus RadioPharma, a CDMO that specializes in the burgeoning field of radiopharmaceuticals, named former FDA Commissioner Dr. Stephen Hahn as its ch...
<a href="https://www.fiercepharma.com/manufacturing/us-manufacturing-push-jj-earmarks-2b-fujifilm-10-year-deal" hreflang="en">In US manufacturing push, J&J earmarks $2B for Fujifilm in 10-year deal in North Carolina</a>
Johnson & Johnson will spend $2 billion over the next 10 years to operate a 160,000-square-foot manufacturing facility at Fujifilm Biotechnologies' ma...
<a href="https://www.fiercepharma.com/marketing/rezolute-resolves-commercial-question-hiring-ex-ultragenyx-exec-ready-rare-disease-launch" hreflang="en">Rezolute resolves commercial question, hiring ex-Ultragenyx exec to ready for rare disease launch</a>
With top-line phase 3 results in sight, Rezolute has stepped up preparations for a planned rare disease launch by appointing Sunil Karnawat as its chi...
<a href="https://www.fiercepharma.com/manufacturing/trump-locks-15-tariff-rate-europe-confirming-separate-most-favored-nation-duty" hreflang="en">UPDATED: Trump locks in 15% pharmaceutical tariff rate for EU, while generic drugs get a pass</a>
A little less than a month after the reveal of a wide-ranging trade deal between the United States and the European Union, the White House has shed mo...
<a href="https://www.fiercepharma.com/pharma/sarepta-extends-700m-debt-2030-adds-private-placement-amid-elevidys-uncertainty" hreflang="en">Sarepta extends $700M debt to 2030, adds private placement amid Elevidys uncertainty</a>
The financing exercise at Sarepta continues as uncertainty remains for the company’s flagship gene therapy Elevidys.
FDA grants Breakthrough Therapy Designation to lung cancer therapy
Upperton Pharma Solutions awarded grant to develop oral vaccine delivery with University of Oxford
Friends of Cancer Research and MMS partner to improve interpretation of cancer trial survival data
ANGLE partners with Myriad Genetics to explore blood-based cancer testing
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago